PT Millennium Pharmacon International Tbk (IDX:SDPC)
Indonesia · Delayed Price · Currency is IDR 186.00
-2.00 (-1.06%)
Feb 10, 2026, 11:59 AM WIB
IDX:SDPC Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3,994,928 | 3,916,864 | 3,363,518 | 3,200,833 | 2,988,849 | 2,643,627 | |
Revenue Growth (YoY) | 3.82% | 16.45% | 5.08% | 7.09% | 13.06% | -3.05% |
Cost of Revenue | 3,655,693 | 3,582,742 | 3,073,699 | 2,933,936 | 2,751,812 | 2,426,333 |
Gross Profit | 339,235 | 334,121 | 289,819 | 266,897 | 237,036 | 217,293 |
Selling, General & Admin | 231,617 | 225,935 | 193,007 | 186,311 | 176,214 | 159,860 |
Other Operating Expenses | 11,160 | 11,752 | 4,096 | 6,687 | 3,348 | 4,662 |
Operating Expenses | 242,777 | 237,688 | 197,102 | 192,998 | 179,562 | 164,522 |
Operating Income | 96,458 | 96,434 | 92,717 | 73,900 | 57,475 | 52,771 |
Interest Expense | -71,001 | -68,791 | -57,577 | -38,482 | -39,894 | -45,117 |
Interest & Investment Income | 268.09 | 59.01 | 139.72 | 984.05 | 80.14 | 84.15 |
EBT Excluding Unusual Items | 25,724 | 27,701 | 35,280 | 36,402 | 17,660 | 7,739 |
Gain (Loss) on Sale of Assets | - | - | 12,681 | 62.49 | 262.22 | 0.85 |
Pretax Income | 25,724 | 27,701 | 47,961 | 36,464 | 17,923 | 7,739 |
Income Tax Expense | 8,913 | 10,787 | 14,880 | 12,000 | 8,351 | 4,935 |
Earnings From Continuing Operations | 16,811 | 16,914 | 33,081 | 24,464 | 9,571 | 2,804 |
Minority Interest in Earnings | -13.17 | 14.75 | 6.33 | - | - | - |
Net Income | 16,798 | 16,929 | 33,088 | 24,464 | 9,571 | 2,804 |
Net Income to Common | 16,798 | 16,929 | 33,088 | 24,464 | 9,571 | 2,804 |
Net Income Growth | -37.49% | -48.84% | 35.25% | 155.60% | 241.30% | -64.41% |
Shares Outstanding (Basic) | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 |
Shares Outstanding (Diluted) | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 |
EPS (Basic) | 13.19 | 13.29 | 25.97 | 19.20 | 7.51 | 2.20 |
EPS (Diluted) | 13.19 | 13.29 | 25.97 | 19.20 | 7.51 | 2.20 |
EPS Growth | -37.49% | -48.84% | 35.25% | 155.60% | 241.30% | -64.41% |
Free Cash Flow | -681.07 | -139,609 | -111,587 | -115,306 | -22,649 | 67,880 |
Free Cash Flow Per Share | -0.54 | -109.58 | -87.59 | -90.51 | -17.78 | 53.28 |
Dividend Per Share | 2.000 | 2.000 | 2.500 | 2.000 | 1.000 | 0.500 |
Dividend Growth | -20.00% | -20.00% | 25.00% | 100.00% | 100.00% | -50.00% |
Gross Margin | 8.49% | 8.53% | 8.62% | 8.34% | 7.93% | 8.22% |
Operating Margin | 2.42% | 2.46% | 2.76% | 2.31% | 1.92% | 2.00% |
Profit Margin | 0.42% | 0.43% | 0.98% | 0.76% | 0.32% | 0.11% |
Free Cash Flow Margin | -0.02% | -3.56% | -3.32% | -3.60% | -0.76% | 2.57% |
EBITDA | 106,105 | 106,975 | 99,149 | 79,868 | 63,699 | 59,617 |
EBITDA Margin | 2.66% | 2.73% | 2.95% | 2.50% | 2.13% | 2.25% |
D&A For EBITDA | 9,647 | 10,541 | 6,433 | 5,968 | 6,225 | 6,846 |
EBIT | 96,458 | 96,434 | 92,717 | 73,900 | 57,475 | 52,771 |
EBIT Margin | 2.42% | 2.46% | 2.76% | 2.31% | 1.92% | 2.00% |
Effective Tax Rate | 34.65% | 38.94% | 31.02% | 32.91% | 46.60% | 63.77% |
Advertising Expenses | - | 2,964 | 2,035 | 1,642 | 8,126 | 8,974 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.